Agarwal, A. D., Jeffrey, S., Ballon, J., Savage, P. "., Xayasak, V., Woolsey, L., Syed, S., Moradkhani, A. M., Chua-Alcala, V. S., Chawla, N. S., Gordon, E. M., Chawla, S. P. (2025). Phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin for advanced leiomyosarcoma and liposaroma (NCT03886311).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e23560